Concept:
The question asks the clinician to evaluate four distinct statements regarding the pathophysiology, surgical management, and diagnostic features of Medullary Thyroid Carcinoma (MTC) and identify the incorrect (false) statement.
Explanation:
• Let us evaluate each statement based on standard endocrine oncology literature.
• Statement A: MTC has a very high propensity for early lymphatic metastasis. Prophylactic ipsilateral or bilateral lateral neck dissection is frequently considered and performed if the primary tumor is large (typically $>1$ to 1.5 cm) or if central compartment nodes are grossly positive. This statement is considered generally true in surgical practice.
• Statement B: MTC unequivocally arises from the neuroendocrine parafollicular C cells of the thyroid gland, which are of neural crest origin. This is a universally true physiological fact.
• Statement C: Parafollicular C cells synthesize and secrete calcitonin, making it the primary, highly sensitive biomarker for MTC. Carcinoembryonic antigen (CEA) is also frequently co-secreted and acts as an important secondary prognostic marker. This statement is true.
• Statement D: Fine Needle Aspiration Cytology (FNAC) is the standard initial test for all thyroid nodules. However, the cytological appearance of MTC is notoriously heterogeneous and deceptive.
• MTC cells on FNAC can appear as spindle-shaped, plasmacytoid, or round cells, frequently mimicking other thyroid neoplasms such as Hürthle cell tumors, anaplastic carcinoma, or even benign lesions.
• Because of this extreme morphological variability, standard H&E staining on FNAC is absolutely NOT "always diagnostic."
• To definitively confirm MTC on cytology, the pathologist must suspect the diagnosis and perform specific immunohistochemical staining for Calcitonin, Chromogranin, or CEA.
• Therefore, the claim that FNAC is highly sensitive and always diagnostic for MTC is factually false.
Final Answer:
Statement D is false because the cytological diagnosis of MTC can be very challenging and requires immunohistochemistry to be definitive.